Status:
COMPLETED
Carnitine Levels and Carnitine Supplementation in Type I Diabetes
Lead Sponsor:
Children's Mercy Hospital Kansas City
Collaborating Sponsors:
Leadiant Biosciences, Inc.
Minimed Pharmaceuticals
Conditions:
Diabetes Mellitus, Type I
Hypoglycemia
Eligibility:
All Genders
7-21 years
Brief Summary
The purpose of this study is to determine whether type I diabetics with carnitine deficiency exhibit increased numbers of hypoglycemic (low blood sugars) events and if unrecognized hypoglycemia occurs...
Detailed Description
Hypoglycemia is a clinical marker of carnitine deficiency. Thus carnitine may compound the risk of hypoglycemia for children on insulin therapy. Currently, one of the limitations in the management of ...
Eligibility Criteria
Inclusion
- Diabetes Mellitus, Type I for greater than 2 years between the ages of 7 and 21
- currently on insulin replacement therapy
Exclusion
- Patients with newly diagnosed Type I diabetes
- Patients already taking L-carnitine
- Patients who come to clinic without glucose monitors
- Patients with known seizure disorders not including hypoglycemic seizures
- Patients on metformin
- Patients with compromised renal function.
Key Trial Info
Start Date :
October 1 2004
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2007
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT00351234
Start Date
October 1 2004
End Date
April 1 2007
Last Update
February 28 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Children's Mercy Hospital
Kansas City, Missouri, United States, 64108